Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesCompany aims to accelerate access to much-needed biosimilar to reference ...

The sector has seen billions in merger and acquisition activity in recent years; a September 2024 analysis by Insight ...

President Donald Trump on Tuesday (Apr 8) said the United States will soon announce a “major” tariff on pharmaceutical ...

Pharma warns EU of US exodus due to tariffs, risking billions in investment, demands policy change for competitiveness.

AbbVie’s Skyrizi and Rinvoq were practically unshakeable atop the monthly TV drug ad spending rankings, ultimately leading ...

Sarepta and Roche will share the monitors' findings with EMA to resolve a temporary hold. Elsewhere, Allakos agreed to a ...

The U.S. Food and Drug Administration (FDA) on Wednesday granted accelerated approval for Novartis AG’s (NYSE:NVS) Vanrafia ...

Annual Results/Sustainability03-Apr-2025 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc ...

Key Insights The considerable ownership by individual investors in Novartis indicates that they collectively have ...

Even statins don’t work on risk factor called lipoprotein (a) that quickly clings to arteries and narrows them ...